Tech Company Financing Transactions
Neuraptive Therapeutics Funding Round
Neuraptive Therapeutics closed a $11.5 million Series A funding round on 12/20/2018. Backers included New Rhein Healthcare Investors and private investors.
Transaction Overview
Company Name
Announced On
12/20/2018
Transaction Type
Venture Equity
Amount
$11,500,000
Round
Series A
Investors
New Rhein Healthcare Investors (Lead Investor)
Proceeds Purpose
The Company will use the funds to further develop its flagship product, the AxoFuse Nerve Repair System (AxoFuse), in clinical trials and to expand operations.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
2697 Trailridge Dr. West
Lafayette, CO 80026
USA
Lafayette, CO 80026
USA
Phone
Website
Email Address
Overview
Neuraptive was founded to commercialize innovative technology from the University of Texas. The Company is dedicated to bringing this technology to patients.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Robert Radie
Founder
David Jackson
VP - Operations
Vicki Abbas
VP - R & D
Evan Tzanis
Browse more venture capital transactions:
Prev: 12/20/2018: DEVCON venture capital transaction
Next: 12/20/2018: Zwift venture capital transaction
Share this article
About Database of VC Transactions
We do our best to report on all VC transactions involving tech companies. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs